ERBB2 (HER2) Testing in Breast Cancer

被引：6
|
作者：
Hilal, Talal [1 ]
Romond, Edward H. [2 ]
机构：
[1] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA
[2] Univ Kentucky, Markey Canc Ctr, Div Med Oncol, Lexington, KY 40536 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 315卷 / 12期
关键词：
NCCTG N9831; SURVIVAL;
D O I：
10.1001/jama.2015.17463
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1280 / 1281
页数：2
相关论文
共 50 条
  • [11] ERBB3/HER3 and ERBB2/HER2 Duet in Mammary Development and Breast Cancer
    David F. Stern
    Journal of Mammary Gland Biology and Neoplasia, 2008, 13
  • [12] ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer
    Stern, David F.
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2008, 13 (02) : 215 - 223
  • [13] Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer Close Enough?
    Burstein, Harold J.
    Schrag, Deborah
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (01): : 30 - 32
  • [14] Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer
    Moutafi, Myrto
    Robbins, Charles J.
    Yaghoobi, Vesal
    Fernandez, Aileen, I
    Martinez-Morilla, Sandra
    Xirou, Vasiliki
    Bai, Yalai
    Song, Yan
    Gaule, Patricia
    Krueger, Joseph
    Bloom, Kenneth
    Hill, Salisha
    Liebler, Daniel C.
    Fulton, Regan
    Rimm, David L.
    LABORATORY INVESTIGATION, 2022, 102 (10) : 1101 - 1108
  • [15] PRACTICE ADVANCES ERBB2 (HER2) Alterations in Colorectal Cancer
    Roy-Chowdhuri, Sinchita
    Davies, Kurtis D.
    Ritterhouse, Lauren L.
    Snow, Anthony N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : 1064 - 1066
  • [16] HER2/ERBB2 immunoreactivity in human retinoblastoma
    Seigel, G. M.
    Sharma, S.
    Hackam, A. S.
    Shah, Dhaval K.
    TUMOR BIOLOGY, 2016, 37 (05) : 6135 - 6142
  • [17] The Mysterious Ways of ErbB2/HER2 Trafficking
    Bertelsen, Vibeke
    Stang, Espen
    MEMBRANES, 2014, 4 (03): : 424 - 446
  • [18] Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer
    Baselga, Jose
    EJC SUPPLEMENTS, 2008, 6 (05): : 1 - 6
  • [19] Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer
    Carmen Duran, M.
    Vega, Francisco
    Moreno-Bueno, Gema
    Jesus Artiga, M.
    Sanchez, Lydia
    Palacios, Jose
    Ridley, Anne
    Timms, John F.
    PROTEOMICS CLINICAL APPLICATIONS, 2008, 2 (09) : 1313 - 1326
  • [20] The erbB2/HER2/neu receptor polymorphism IIe655Val and breast cancer
    Cox, DG
    Hankinson, SE
    Hunter, DJ
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (07): : 447 - 450
12345